Tizanidine Tablet
Product Images NDC 60760-505

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Tizanidine (NDC 60760-505). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by St. Mary's Medical Park Pharmacy, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Tiz (Tizanidine 60760 505 15)

Label for Tizanidine Tablets, USP 4 mg, showing tablet quantity of 15. The label includes NDC 60760-505-15, and states packaging by St. Mary's Medical Park Pharmacy, Oro Valley, AZ. Storage instructions specify controlled room temperature 15°-30°C (59°-86°F). Manufacturer is Dr. Reddy's Laboratories, India.*

FDA Label Image

Fig1 (Fig1)

A line graph depicting plasma Tizanidine concentration (ng/mL) over time (hours) from dosing. It compares four conditions: 2 x 4 mg Tizanidine tablets with food, without food, and 2 x 4 mg Tizanidine capsules with food, without food, showing concentration peaks within approximately 2 hours followed by decline up to 24 hours.*

FDA Label Image

Fig2 (Fig2)

A line graph depicting improvement in Ashworth Score over time (hours post-dose) for three groups: placebo, 8 mg tizanidine, and 16 mg tizanidine. The y-axis shows improvement in Ashworth Score, and the x-axis shows hours post-dose from 0 to 6. Data points include error bars for variability.*

FDA Label Image

Fig3 (Fig3)

A line graph comparing the improvement in Ashworth Score over time between tizanidine (mean dose 28.8 mg) and placebo groups. The x-axis represents three time points: End of Titration (Study Week 3), End of Maintenance (Study Week 7), and Endpoint (Last Observation Carried Forward). The y-axis shows improvement scores, with negative values indicating improvement. Error bars indicate variability at each time point for both groups.*

FDA Label Image

Structure (Structure)

Chemical structure of Tizanidine, depicted as a molecular diagram showing its heterocyclic rings and chlorine atom, including the hydrochloride (HCl) component as part of the structure.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.